DSM43 is a dihydroorotate dehydrogenase (DHODH) inhibitor. Malaria puts at risk nearly half the world's population and causes high mortality in sub-Saharan Africa, while drug resistance threatens current therapies. The pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH) is a validated target for malaria treatmen
7α-Hydroxy-3-oxochol-4-en-24-oic Acid-[13C3] in Methanol (Standard)是7α-Hydroxy-3-oxochol-4-en-24-oic Acid-[13C3] in Methanol的标准品,适用于定量分析、质量控制及生化实验等相关研究。